Geftinat 250 Mg Tablet contains the active ingredient gefitinib and is usually prescribed when other treatments have failed or when the cancer has spread. It is a medication used in the treatment of non-small cell lung cancer (NSCLC) that has certain genetic mutations, such as mutations in the epidermal growth factor receptor (EGFR) gene. Gefitinib is a tyrosine kinase inhibitor that works by inhibiting the activity of the EGFR protein, which is involved in the growth and spread of cancer cells. Geftinat 250 Mg Tablet is effective in the treatment of NSCLC with certain EGFR mutations, leading to improvements in progression-free survival and overall survival in some patients.
Specification
|
Packaging Size |
30 Tablets |
|
Form |
Tablet |
|
Packaging Type |
Bottle |
|
Treatment |
Non-small cell lung cancer |
|
Manufacturer |
Natco |
|
Dose/Strength |
250 MG |

Price:
Price 3000 INR / Box
Minimum Order Quantity : 100 Bottles
Grade : Pharma
Dosage : 140 mg
Usage : Hospital
Storage : Dry Place
Price 18000 INR / Box
Minimum Order Quantity : 100 Bottles
Grade : Pharma
Dosage : 100 mg & 400 mg
Usage : Hospital
Storage : Dry Place
Price 500 INR / Box
Minimum Order Quantity : 100 Boxes
Grade : Pharma
Dosage : 10 mg
Usage : Hospital
Storage : Dry Place
Price 500 INR / Box
Minimum Order Quantity : 100 Strips
Grade : Pharma
Dosage : 250mg
Usage : Hospital
Storage : Dry Place